SAN FRANCISCO, May 21, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on June 3, 2013, to discuss the Company's financial results for the fourth quarter and full year of fiscal 2013 and to provide an update about the business in the current fiscal year.
The dial-in number for the live audio call beginning on Monday, June 3, 2013, at 5 p.m. EDT (2 p.m. PDT) is (877) 369-6591 in the U.S. and (253) 237-1176 for international participants. The conference identification number is 73634657. A live webcast of the conference call will also be available at:
A webcast replay of the call will be available for one year and may be accessed at the same link:
CollabRx, Inc. (Nasdaq:CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
CONTACT: CollabRx Contacts: Thomas R. Mika, Chairman and CEO CollabRx, Inc. 415-248-5350 Robert Ferri Partners, LLC Robert Ferri (415) 575-1589 (direct) email@example.com